Intech Investment Management LLC lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 27.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 200,656 shares of the company's stock after selling 75,613 shares during the period. HCA Healthcare makes up 0.7% of Intech Investment Management LLC's holdings, making the stock its 20th biggest position. Intech Investment Management LLC owned approximately 0.08% of HCA Healthcare worth $69,337,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of HCA Healthcare by 11.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company's stock worth $8,796,000 after acquiring an additional 2,698 shares in the last quarter. Brown Advisory Inc. increased its position in shares of HCA Healthcare by 53.9% in the first quarter. Brown Advisory Inc. now owns 4,630 shares of the company's stock valued at $1,600,000 after buying an additional 1,622 shares in the last quarter. Farther Finance Advisors LLC lifted its position in shares of HCA Healthcare by 26.9% during the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock valued at $395,000 after buying an additional 242 shares in the last quarter. Oppenheimer Asset Management Inc. increased its holdings in HCA Healthcare by 2.5% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock worth $1,491,000 after acquiring an additional 105 shares in the last quarter. Finally, GAMMA Investing LLC lifted its holdings in HCA Healthcare by 17.6% during the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock valued at $1,704,000 after purchasing an additional 737 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the company. Cantor Fitzgerald reiterated an "overweight" rating and issued a $444.00 price objective on shares of HCA Healthcare in a report on Tuesday, August 26th. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Morgan Stanley lowered their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research note on Monday, July 28th. Robert W. Baird raised their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. Finally, JPMorgan Chase & Co. raised their target price on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $403.17.
Read Our Latest Analysis on HCA
HCA Healthcare Stock Up 0.7%
Shares of HCA Healthcare stock traded up $2.69 during trading hours on Friday, reaching $405.54. 761,184 shares of the company were exchanged, compared to its average volume of 1,129,364. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $420.98. The firm has a market cap of $94.89 billion, a PE ratio of 17.05, a PEG ratio of 1.27 and a beta of 1.41. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The stock's fifty day moving average is $382.88 and its 200 day moving average is $362.77.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is currently 12.11%.
Insider Activity
In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm's stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.30% of the stock is currently owned by company insiders.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report